Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Usefulness of Combination Therapy of Rapid Acting Insulin Secretagogue (Glinide) With Premixed Insulin in Type 2 Diabetes

NCT00369148 is registered in ClinicalTrials.gov with Keio University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00369148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Usefulness of Combination Therapy of Rapid Acting Insulin Secretagogue (Glinide) With Premixed Insulin in Type 2 Diabetes
Lead sponsor
Keio University
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2004
Completion date
March 31, 2006
Enrollment
60
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabets mellitus